Status
Conditions
Treatments
About
In certain cases (e.g.: patient who are difficult to perfuse, thin veins, etc.), an increase in venipunctures performed by study nurses in healthcare services can lead to a loss of venous capital, repeated pain during punctures, discontinuous treatment follow-up and numerous requests for assistance from colleagues, including nurse anesthetists, but often too late.
The main objective of project is to reduce the number of punctures to access the venous system after evaluation of adult patients upon entering the hospitalization department using the A-DIVA tool. the A-DIVA score predicts the difficulty in infusing an adult patient
Full description
This research evaluates the importance of assessing the venous capital access of hospitalized patients prior to the placement of an intravenous infusion, in order to save time in initiating therapeutic treatment and to prevent or reduce the number of venipunctures and the associated inconveniences (pain, discontinuous treatment monitoring). This approach aims to preserve the patient's venous capital.
In the proposed study, investigators will evaluate the patients' venous capital using the Adult-Difficult IntraVenous Access (A-DIVA) tool upon hospital admission and during hospitalization before any peripheral intravenous (IV) catheter placement.
During the inclusion visit, after obtaining informed consent, patients will be randomized into one of two groups:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients in Intensive Care Units
Patients with Psychiatric Disorders or Under Psychiatric Care
Minor Patients Under 18 Years of Age
Pregnant or Breastfeeding Women
Vulnerable and Protected Individuals as Defined by the Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2)
Patients Participating in Another Interventional Study
Dying patients
Patients Receiving Infusions of:
Patients refusing to participate in the study
Primary purpose
Allocation
Interventional model
Masking
600 participants in 2 patient groups
Loading...
Central trial contact
Eric MORTUREUX, PI
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal